BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba signs an agreement with Metron Technology to enter the Chinese cosmetics market

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba, a French company specializing in microbiological solutions, has signed a memorandum of understanding with Metron Technology, a subsidiary of the Oriental Beauty Valley (OBV) group in China. This partnership aims to approve and distribute a natural cosmetic ingredient in China.

Shanghai-based Oriental Beauty Valley is a recognized hub supported by the Chinese government for the development of the cosmetics sector. With over 1,000 companies, OBV will provide Amoéba with a favorable environment for innovation and compliance with local regulatory standards.

This partnership marks a strategic step forward for Amoéba, which is preparing to strengthen its presence in the Chinese market, estimated at $85 billion. The company hopes to convert approval in China into global opportunities with high margins.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news